{"id":"NCT01081145","sponsor":"Shire","briefTitle":"Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)","officialTitle":"A Phase 3, Double-blind, Placebo-controlled, Multicentre, Randomised Withdrawal, Long-term Maintenance of Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 With Attention Deficit/Hyperactivity Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-05-11","primaryCompletion":"2013-06-03","completion":"2013-06-03","firstPosted":"2010-03-05","resultsPosted":"2014-06-09","lastUpdate":"2021-06-14"},"enrollment":528,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Attention-deficit/Hyperactivity Disorder"],"interventions":[{"type":"DRUG","name":"Extended-release Guanfacine Hydrochloride","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Extended-release Guanfacine HCl","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to evaluate the long-term maintenance of efficacy of Extended-Release Guanfacine HCl in children and adolescents (6-17 years) with attention-deficit/hyperactivity disorder (ADHD) who respond to an initial open-label, short term treatment with SPD503.","primaryOutcome":{"measure":"Percentage of Participants With Treatment Failures During the Double-Blind Randomized-Withdrawal Phase","timeFrame":"26 weeks","effectByArm":[{"arm":"Placebo","deltaMin":64.9,"sd":null},{"arm":"Guanfacine Hydrochloride","deltaMin":49.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.006"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":81,"countries":["United States","Belgium","Canada","France","Germany","Italy","Netherlands","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["26871297"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":526},"commonTop":["Somnolence","Headache","Fatigue","Abdominal pain upper","Nasopharyngitis"]}}